IDEAYA Biosciences, Inc. (FRA:30J)
Germany · Delayed Price · Currency is EUR 30.60
-0.40 (-1.29%)
Last updated: Dec 1, 2025, 8:04 AM CET
IDEAYA Biosciences Market Cap
IDEAYA Biosciences has a market cap or net worth of €2.59 billion as of December 1, 2025. Its market cap has increased by 3.83% in one year.
Market Cap
2.59B
Enterprise Value
1.63B
Revenue
183.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
€30.60
Market Cap Chart
Since May 23, 2019, IDEAYA Biosciences's market cap has increased from 193.04M to 2.59B, an increase of 1,240.31%. That is a compound annual growth rate of 48.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 2.59B | 20.59% |
| Dec 31, 2024 | 2.15B | 3.41% |
| Dec 29, 2023 | 2.07B | 153.65% |
| Dec 30, 2022 | 818.01M | 2.24% |
| Dec 31, 2021 | 800.08M | 140.60% |
| Dec 31, 2020 | 332.54M | 146.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |